{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:40:02Z","timestamp":1776487202437,"version":"3.51.2"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,4,15]]},"DOI":"10.2169\/internalmedicine.5631-25","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T22:08:20Z","timestamp":1758146900000},"page":"1168-1171","source":"Crossref","is-referenced-by-count":0,"title":["Severe Bilateral Optic Neuritis and a Tumefactive Demyelinating Lesion in Pregnancy"],"prefix":"10.2169","volume":"65","author":[{"given":"Ryo","family":"Sasaki","sequence":"first","affiliation":[{"name":"Department of Neurology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutoshi","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1038\/s41433-023-02477-0","volume":"37","author":"N Moheb","year":"2023","unstructured":"1. Moheb N, Chen JJ. The neuro-ophthalmological manifestations of NMOSD and MOGAD - a comprehensive review. Eye 37: 2391-2398, 2023.","journal-title":"Eye","ISSN":"https:\/\/id.crossref.org\/issn\/0078-5334","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nakayama M, Naganawa S, Ouyang M, et al. A review of clinical and imaging findings in tumefactive demyelination. AJR Am J Roentgenol 217: 186-197, 2021.","DOI":"10.2214\/AJR.20.23226"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Qiu K, He Q, Chen X, Liu H, Deng S, Lu W. Pregnancy-related immune changes and demyelinating diseases of the central nervous system. Front Neurol 10: 1070, 2019.","DOI":"10.3389\/fneur.2019.01070"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17: 162-173, 2018.","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Codjia P, Ayrignac X, Carra-Dalliere C, et al.; SFSEP and OFSEP. Multiple sclerosis with atypical MRI presentation: results of a nationwide multicenter study in 57 consecutive cases. Mult Scler Relat Disord 28: 109-116, 2019.","DOI":"10.1016\/j.msard.2018.12.022"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Anderson A, Krysko KM, Rutatangwa A, et al. Clinical and radiologic disease activity in pregnancy and postpartum in MS. Neurol Neuroimmunol Neuroinflamm 8: e959, 2021.","DOI":"10.1212\/NXI.0000000000000959"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Collongues N, Alves Do, Rego C, et al. Pregnancy in patients with AQP4-Ab, MOG-Ab, or double-negative neuromyelitis optica disorder. Neurology 96: e2006-e2015, 2021.","DOI":"10.1212\/WNL.0000000000011744"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. D&apos;Souza R, Wuebbolt D, Andrejevic K, et al. Pregnancy and neuromyelitis optica spectrum disorder - reciprocal effects and practical recommendations: a systematic review. Front Neurol 11: 544434, 2020.","DOI":"10.3389\/fneur.2020.544434"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bai W, Sun M, Song H, et al. Serial analyses of clinical spectra and outcomes in Chinese women with pregnancy-induced optic neuritis. Front Med (Lausanne) 9: 1067277, 2022.","DOI":"10.3389\/fmed.2022.1067277"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pakneshan S, Bernitsas E. Fulminant tumefactive multiple sclerosis in pregnancy. BMJ Case Rep 2017: bcr2017219534, 2017.","DOI":"10.1136\/bcr-2017-219534"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hardy TA, Weinshenker BG. Relapsing tumefactive demyelination: time to recognize a distinct demyelinating condition? Mult Scler J 30: 1838-1839, 2024.","DOI":"10.1177\/13524585241273075"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nakamura M, Itani K, Miyake K, Kunieda T, Kaneko S, Kusaka H. Natalizumab is effective for the treatment of relapsing-remitting tumefactive multiple sclerosis. Intern Med 56: 211-214, 2017.","DOI":"10.2169\/internalmedicine.56.7588"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ahern C. Paradoxical tumefactive worsening of multiple sclerosis after natalizumab initiation: a case report. touchREVIEWS in Neurology 19: 19-22, 2023.","DOI":"10.17925\/USN.2023.19.2.25"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bazzurri V, Curti E, Tsantes E, Fiore A, Franceschini A, Granella F. Ocrelizumab in tumefactive multiple sclerosis onset. A case report. Neuroimmunol Rep 2: 100122, 2022.","DOI":"10.1016\/j.nerep.2022.100122"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yeh WZ, Van Der, Walt A, et al. Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies. Neurol Neuroimmunol Neuroinflamm 11: e200328, 2024.","DOI":"10.1212\/NXI.0000000000200328"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 36: 248-255, 1996.","DOI":"10.1111\/j.1600-0897.1996.tb00172.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hefner S, Casaccia TL, Hofstaetter E, Otto F, Hellwig K, Moser T. Impact of continuous ofatumumab exposure during pregnancy in multiple sclerosis. Neurol Clin Pract 15: e200410, 2025.","DOI":"10.1212\/CPJ.0000000000200410"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. S\u00e1nchez-Pav\u00f3n E, Mendoza H, Garc\u00eda-Ferreyra J. Trisomy 21 and assisted reproductive technologies: a review. JBRA Assist Reprod 17: 129-141, 2022.","DOI":"10.5935\/1518-0557.20210047"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/8\/65_5631-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:50:42Z","timestamp":1776484242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/8\/65_5631-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5631-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"5631-25"}}